Last checked at 
LONDON (Alliance News) - OptiBiotix Health PLC said Friday it has inked a development agreement with Italy-based Centro Sperimentale Del Latte SRL to synthesise and purify oligosaccharides, meaning carbohydrates that consist of a small number of sugars, from microbial strains.
Centro Sperimentale Del Latte researches, develops, manufactures and distributes probiotics, starter cultures, moulds and yeasts for the pharmaceutical, nutraceutical, dairy, food and agricultural sectors.
"This development agreement reflects the progress we have made with our OptiBiotic technology platform. Increasing the number of microbial species is an exciting extension of our existing programme which broadens the range of product and partner opportunities," said Chief Executive Officer Stephen O'Hara in a statement.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
